According to the recent study the medical device reprocessing market is projected to reach an estimated $4.5 billion by 2028 from $2.2 billion in 2023, at a CAGR of 15.2% from 2023 to 2028. Growth in this market is primarily driven by increasing demand for medical supplies globally, low prices of reprocessed medical devices, and growing awareness and campaigns from NGOs to reduce the volume of medical waste generated.

A more than 150 – page report is developed to understand trends, opportunities and forecast in medical device reprocessing market by products & services (reprocessing support & services and reprocessing medical devices), device type (critical devices, semi-critical devices, and non-critical devices), application (cardiology, gastroenterology, gynaecology, arthroscopy & orthopedic surgery, general surgery and anesthesia, and others), end use industry (hospitals, ambulatory surgical centers, and home healthcare), and region (North America, Europe, Asia Pacific, and the Rest of the World).

“Reprocessing support & services market is expected to remain the largest segment during the forecast period.”

Based on products & services, the medical device reprocessing market is segmented into reprocessing support & services and reprocessing medical devices. Lucintel forecasts that the reprocessing support & services market is expected to remain the largest segment due to growing acceptance of third party reprocessing services by healthcare facilities owing to reduced in-house reprocessing costs.

“Within the medical device reprocessing market, the cardiology segment is expected to remain the largest application”

Based on application the cardiology segment is expected to witness the highest growth over the forecast period due to widespread presence of cardiac diseases that leads to increasing demand for diagnostic and surgical procedures.

“Asia pacific will dominate the medical device reprocessing market in near future”

APAC will remain the highest growing segment over the forecast period due to on-going technological advancements for automation and increasing awareness associated with reprocessed medical devices in the region.

Major players of medical device reprocessing market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Stryker Corporation, Johnson & Johnson, Vanguard AG, Medtronic, Steris Healthcare, Innovative Health, Northeast Scientific, Cardinal Health, Medsalv, and Arjo Group are among the major medical device reprocessing providers.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com